ANN RAIKES HARTLEY: Open Payments
NPI 1225385818 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 13 payments from 7 companies in 2025. Trend: 2023 $753 · 2024 $288 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $30 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Ozempic, Kerendia, XIFAXAN, INSPIRE, REXULTI, JARDIANCE, FARXIGA.
Industry payments across FL — which companies pay providers there.
